MRSAid is a novel non-antibiotic therapy developed for use in hospital/long-term care settings for nasal decolonization of potentially pathogenic bacteria, including MRSA. Developed by Ondine Biomedical Inc., the global leaders in antimicrobial photodynam
MRSAid is a novel non-antibiotic therapy developed for use in hospital/long-term care settings for nasal decolonization of potentially pathogenic bacteria, including MRSA. Developed by Ondine Biomedical Inc., the global leaders in antimicrobial photodynam
Sinuwave is a therapy that is under development for the treatment of Chronic Sinusitis. It leverages the experience from Ondine Biomedical Inc, the global leader in photodynamic solutions.
Sinuwave is a therapy that is under development for the treatment of Chronic Sinusitis. It leverages the experience from Ondine Biomedical Inc, the global leader in photodynamic solutions.
Ondine Biomedical Inc. is dedicated to the development of non-antibiotic, anti-infective therapies for a broad spectrum of bacterial, viral and fungal infections.
MRSAid is a novel non-antibiotic therapy developed for use in hospital/long-term care settings for nasal decolonization of potentially pathogenic bacteria, including MRSA. Developed by Ondine Biomedical Inc., the global leaders in antimicrobial photodynam
MRSAid is a novel non-antibiotic therapy developed for use in hospital/long-term care settings for nasal decolonization of potentially pathogenic bacteria, including MRSA. Developed by Ondine Biomedical Inc.
MRSAid is a novel non-antibiotic therapy developed for use in hospital/long-term care settings for nasal decolonization of potentially pathogenic bacteria, including MRSA. Developed by Ondine Biomedical Inc., the global leaders in antimicrobial photodynam
Sinuwave is a therapy that is under development for the treatment of Chronic Sinusitis. It leverages the experience from Ondine Biomedical Inc, the global leader in photodynamic solutions.
Sinuwave is a therapy that is under development for the treatment of Chronic Sinusitis. It leverages the experience from Ondine Biomedical Inc, the global leader in photodynamic solutions.